Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) Final Billing and Coding Article - Effective December 26, 2022

This Local Coverage Determination (LCD) has completed the Open Public Meeting and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number/Contractor Determination Number: A58973

Billing and Coding Article Title: Billing and Coding MolDX: Plasma-Based Genomic Profiling in Solid Tumors

Effective Date: December 26, 2022

Summary of LCA: The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Plasma-Based Genomic Profiling in Solid Tumors L39230.

Visit the Proposed LCDs webpage to access this Billing and Coding Article.

 

            Last Updated Mon, 14 Nov 2022 21:35:19 +0000